Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Schram, AM"'
Autor:
Drilon, A, Duruisseaux, M, Han, JY, Ito, M, Falcon, C, Yang, SR, Murciano-Goroff, YR, Chen, HQ, Okada, M, Molina, MA, Wislez, M, Brun, P, Dupont, C, Branden, E, Rossi, G, Schrock, A, Ali, S, Gounant, V, Magne, F, Blum, TG, Schram, AM, Monnet, I, Shih, JY, Sabari, J, Perol, M, Zhu, VW, Nagasaka, M, Doebele, R, Camidge, DR, Arcila, M, Ou, SHI, Moro-Sibilot, D, Rosell, R, Muscarella, LA, Liu, SV, Cadranel, J
Publikováno v:
Journal of Clinical Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
PURPOSE Although NRG1 fusions are oncogenic drivers across multiple tumor types including lung cancers, these are difficult to study because of their rarity. The global eNRGy1 registry was thus established to characterize NRG1 fusion-positive lung ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c8d09b1ebe67fbd59c0f4fa20e000f5b
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1806
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1806
Publikováno v:
OncoTargets and Therapy, Vol Volume 10, Pp 1983-1992 (2017)
Joshua K Sabari,1 Fernando C Santini,1,2 Alison M Schram,2 Isabella Bergagnini,1 Ruqin Chen,1 Chebli Mrad,1 W Victoria Lai,1 Kathryn C Arbour,1 Alexander Drilon2,3 1Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine,
Publikováno v:
Archives of Dermatology; Feb2012, Vol. 148 Issue 2, p270-271, 2p
Autor:
Movva S; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Seier K; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Avutu V; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Banks LB; Memorial Sloan Kettering Cancer Center, United States., Chan J; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Chi P; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Dickson MA; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Gounder MM; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Kelly CM; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Keohan ML; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Maki R; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Rosenbaum E; Memorial Sloan Kettering Cancer Center, New York, United States., Salcito T; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Rodriguez K; Memorial Sloan Kettering Cancer Center, United States., Dempsey R; Memorial Sloan Kettering Cancer Center, United States., Meyers PA; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Cohen SM; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Hensley ML; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Konner JA; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Lefkowitz RA; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Erinjeri JP; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Qin LX; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Tap WD; Memorial Sloan Kettering Cancer Center, New York, NY, United States., D'Angelo SP; Memorial Sloan Kettering Cancer Center, New York, NY - New York, United States.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.
Autor:
Bhamidipati D; SUNY Downstate Medical Center, United States., Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Autor:
Westphalen CB; Comprehensive Cancer Center Munich & Department of Medicine III, University Hospital, LMU Munich, Munich; German Cancer Consortium (DKTK), partner site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: education@esmo.org., Martins-Branco D; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland., Beal JR; Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Cardone C; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy., Coleman N; School of Medicine, Trinity College Dublin, Dublin; Medical Oncology Department, St. James's Hospital, Dublin; Trinity St. James's Cancer Institute, Dublin, Ireland., Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City; Weill Cornell Medical College, New York City., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham; Duke Cancer Institute, Duke University, Durham, USA., Michiels S; Oncostat U1018, Inserm, Université Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif; Service de Biostatistique et Epidémiologie, Gustave Roussy, Villejuif, France., Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., André F; INSERM U981, Gustave Roussy, Villejuif; Department of Cancer Medicine, Gustave Roussy, Villejuif; Faculty of Medicine, Université Paris-Saclay, Kremlin Bicêtre., Bibeau F; Service d'Anatomie Pathologique, CHU Besançon, Université de Bourgogne Franche-Comté, Besançon, France., Curigliano G; Istituto Europeo di Oncologia, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Kummar S; Division of Hematology and Medical Oncology, Department of Medicine, Knight Cancer Institute, Oregon Health and Science University, Portland., Kurzrock R; Department of Medicine, Medical College of Wisconsin Cancer Center, Milwaukee, USA., Limaye S; Medical & Precision Oncology, Sir H. N. Reliance Foundation Hospital & Research Centre, Mumbai, India., Loges S; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), German Center for Lung Research (DZL), German Cancer Consortium (DKTK), Heidelberg, Germany., Marabelle A; Drug Development Department (DITEP) and Laboratory for Translational Research in Immunotherapy (LRTI), Gustave Roussy, INSERM U1015 & CIC1428, Université Paris-Saclay, Villejuif, France., Marchió C; Department of Medical Sciences, University of Turin, Turin; Division of Pathology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Rodon J; Department of Investigational Cancer Therapeutics, UT MD Anderson, Houston, USA., Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia., Pentheroudakis G; Scientific and Medical Division, European Society for Medical Oncology (ESMO), Lugano, Switzerland., Subbiah V; Early-Phase Drug Development, Sarah Cannon Research Institute (SCRI), Nashville, USA.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Aug 24. Date of Electronic Publication: 2024 Aug 24.
Autor:
Murciano-Goroff YR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Uppal M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Chen M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Harada G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.
Publikováno v:
Annual review of cancer biology [Annu Rev Cancer Biol] 2024 Jun; Vol. 8 (1), pp. 59-80. Date of Electronic Publication: 2023 Dec 05.
Autor:
Walmsley CS; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Jonsson P; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Cheng ML; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., McBride S; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Kaeser C; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Vargas HA; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Laudone V; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Taylor BS; Loxo Oncology at Lilly, Stamford, CT, USA., Kappagantula R; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Baez P; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Richards AL; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Noronha AM; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Perera D; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Berger M; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Solit DB; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Iacobuzio-Donahue CA; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Scher HI; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Donoghue MTA; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Abida W; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Schram AM; Memorial Sloan Kettering Cancer Center, New York City, NY, USA. schrama@mskcc.org.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2024 Feb 14; Vol. 8 (1), pp. 34. Date of Electronic Publication: 2024 Feb 14.
Autor:
Varkaris A; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Pazolli E; Relay Therapeutics, Inc., Cambridge, Massachusetts., Gunaydin H; Relay Therapeutics, Inc., Cambridge, Massachusetts., Wang Q; D. E. Shaw Research, New York, New York., Pierce L; Relay Therapeutics, Inc., Cambridge, Massachusetts., Boezio AA; Relay Therapeutics, Inc., Cambridge, Massachusetts., Bulku A; Relay Therapeutics, Inc., Cambridge, Massachusetts., DiPietro L; Relay Therapeutics, Inc., Cambridge, Massachusetts., Fridrich C; Relay Therapeutics, Inc., Cambridge, Massachusetts., Frost A; Altos Labs, Institute of Science, San Francisco, California.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California.; California Institute of Quantitative Biosciences (QB3), University of California San Francisco, San Francisco, California., Giordanetto F; D. E. Shaw Research, New York, New York., Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee., Harris K; MGH/Mass General Cancer Center at Danvers, Danvers, Massachusetts., Holliday M; Relay Therapeutics, Inc., Cambridge, Massachusetts., Hunter TL; Relay Therapeutics, Inc., Cambridge, Massachusetts., Iskandar A; Relay Therapeutics, Inc., Cambridge, Massachusetts., Ji Y; Hematology/Oncology, Exeter Hospital, Exeter, New Hampshire., Larivée A; Paraza Pharma, Inc. Montreal, Canada., LaRochelle JR; Relay Therapeutics, Inc., Cambridge, Massachusetts., Lescarbeau A; Relay Therapeutics, Inc., Cambridge, Massachusetts., Llambi F; Relay Therapeutics, Inc., Cambridge, Massachusetts., Lormil B; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Mader MM; Relay Therapeutics, Inc., Cambridge, Massachusetts., Mar BG; Relay Therapeutics, Inc., Cambridge, Massachusetts., Martin I; Relay Therapeutics, Inc., Cambridge, Massachusetts., McLean TH; Relay Therapeutics, Inc., Cambridge, Massachusetts., Michelsen K; Relay Therapeutics, Inc., Cambridge, Massachusetts., Pechersky Y; D. E. Shaw Research, New York, New York., Puente-Poushnejad E; Relay Therapeutics, Inc., Cambridge, Massachusetts., Raynor K; Relay Therapeutics, Inc., Cambridge, Massachusetts., Rogala D; Relay Therapeutics, Inc., Cambridge, Massachusetts., Samadani R; Relay Therapeutics, Inc., Cambridge, Massachusetts., Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Shortsleeves K; Relay Therapeutics, Inc., Cambridge, Massachusetts., Swaminathan S; Relay Therapeutics, Inc., Cambridge, Massachusetts., Tajmir S; MGH Radiology, Harvard Medical School, Boston, Massachusetts., Tan G; Relay Therapeutics, Inc., Cambridge, Massachusetts., Tang Y; Relay Therapeutics, Inc., Cambridge, Massachusetts., Valverde R; Relay Therapeutics, Inc., Cambridge, Massachusetts., Wehrenberg B; Relay Therapeutics, Inc., Cambridge, Massachusetts., Wilbur J; Relay Therapeutics, Inc., Cambridge, Massachusetts., Williams BR; Relay Therapeutics, Inc., Cambridge, Massachusetts., Zeng H; Relay Therapeutics, Inc., Cambridge, Massachusetts., Zhang H; Relay Therapeutics, Inc., Cambridge, Massachusetts., Walters WP; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Wolf BB; Relay Therapeutics, Inc., Cambridge, Massachusetts., Shaw DE; D. E. Shaw Research, New York, New York.; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York., Bergstrom DA; Relay Therapeutics, Inc., Cambridge, Massachusetts., Watters J; Relay Therapeutics, Inc., Cambridge, Massachusetts., Fraser JS; California Institute of Quantitative Biosciences (QB3), University of California San Francisco, San Francisco, California.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California., Fortin PD; Relay Therapeutics, Inc., Cambridge, Massachusetts., Kipp DR; Relay Therapeutics, Inc., Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Feb 08; Vol. 14 (2), pp. 240-257.
Autor:
Garralda E; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA., Bedard PL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Schwartz GK; Columbia University Vagelos School of Medicine, Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Yuen E; Eli Lilly and Company, Indianapolis, IN, USA., McNeely SC; Eli Lilly and Company, Indianapolis, IN, USA., Ribeiro S; Eli Lilly and Company, Indianapolis, IN, USA., Cunningham J; Eli Lilly and Company, Indianapolis, IN, USA., Wang Y; Eli Lilly and Company, Indianapolis, IN, USA., Urunuela A; Eli Lilly and Company, Indianapolis, IN, USA., Xu X; Eli Lilly and Company, Indianapolis, IN, USA., LoRusso P; Yale Cancer Center, New Haven, CT, USA.
Publikováno v:
The oncologist [Oncologist] 2024 Jan 05; Vol. 29 (1), pp. e131-e140.